Clinical Updates in the Treatment and Care of Patients With Waldenström Macroglobulinemia

This activity was originally broadcast live as a satellite symposium held in conjunction with HOPA 2022.

Program Description

Waldenström macroglobulinemia (WM) is a rare, incurable hematologic malignancy. Patient presentation is variable, ranging from asymptomatic to symptoms including hyperviscosity, neuropathy, and fever. Traditionally, WM has been treated with systemic chemotherapy; however, the use of oral Bruton's tyrosine kinase inhibitors, proteasome inhibitors, and monoclonal antibodies are now incorporated into clinical practice guidelines. This activity will focus on available drug therapies for the treatment of WM as well as clinical data supporting use of the agents. Additionally, the role of the pharmacist in assisting in patient care will be emphasized. Expert clinical faculty will guide learners through several patient case scenarios, allowing the opportunity for audience engagement in optimal therapy selection and adverse effect management.

Target audience: Oncology pharmacists

Type of activity: Application
Release date: April 29, 2022
Expiration date: April 29, 2023

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine the pathophysiology underlying Waldenström macroglobulinemia (WM), the clinical presentation, and associated complications
• Illustrate the current and emerging paradigm for the management of WM
• Identify the role of the pharmacist in implementing supportive care strategies to optimize outcomes for patients with WM

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-22-193-H01-P. The activity is available for CE credit through April 29, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, watch the symposium in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Faculty

Karen M. Fancher, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:

Consultant: AstraZeneca Pharmaceuticals, BTG Specialty Pharmaceuticals, G1 Therapeutics, Merck & Co

Speakers Bureau: G1 Therapeutics

Joslyn Rudoni, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:

Consultant: AbbVie, BTG Medical, GSK, Seagen, Janssen, AstraZeneca, CBPartners/Exerter Pharma Consultancy, HMP Global, Horizon CME

Speakers Bureau: Sanofi

Jordan Miller, PharmD, BCPS, BCOP, CPP, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Meg Taylor, PharmD, CPP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer

CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms